Validea’s guru fundamental report for ALNYLAM PHARMACEUTICALS, INC. (ALNY) shows it rates highest using the Twin Momentum Investor model by Dashan Huang. ALNY is a large-cap growth stock in Biotechnology & Drugs, with a 94% rating based on fundamentals and valuation. The stock meets the strategy’s tests for fundamental and twelve minus one momentum, resulting in a final rank pass. Dashan Huang, Assistant Professor of Finance at Singapore Management University, identified seven fundamental variables for market outperformance. Validea offers investment research services based on the strategies of investment legends like Warren Buffett and Peter Lynch.

Read more at Nasdaq: Validea Detailed Fundamental Analysis – ALNY